|
|
|
|
| LEADER |
02691nam a2200337 u 4500 |
| 001 |
EB002001595 |
| 003 |
EBX01000000000000001164496 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Brett, Kendra
|
| 245 |
0 |
0 |
|a Triclosan in single use medical devices for preventing infections
|h Elektronische Ressource
|b a review of clinical effectiveness, safety and guidelines
|c Kendra Brett, Charlene Argáez
|
| 246 |
3 |
1 |
|a Triclosan for single use medical devices for preventing infections
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c July 11, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (42 pages)
|b illustrations
|
| 653 |
|
|
|a Anti-Infective Agents, Local / therapeutic use
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Surgical Wound Infection / prevention & control
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Evidence-Based Practice
|
| 653 |
|
|
|a Triclosan / therapeutic use
|
| 653 |
|
|
|a Practice Guidelines as Topic
|
| 700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546323
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Triclosan is a synthetic antimicrobial compound. At low concentrations, triclosan suppresses the growth of numerous bacteria, and at higher concentrations, it can rapidly kill bacteria. Due to its antiseptic and disinfectant properties, triclosan is used in numerous products, including personal care products (e.g., hand soap), household items (e.g., cutting boards), and medical devices (e.g. sutures, catheters). Wider use of antiseptics and antimicrobials has been suggested for surgical practice, however, it is unclear whether using triclosan on single use medical devices or consumables (e.g., sutures) is likely to provide a significant benefit in reducing infections in hospitalized patients. The purpose of this report is to synthesize and critically appraise the available evidence on the clinical effectiveness and safety of using triclosan on single use medical devices or consumables for infection prevention in hospitalized patients. Additionally, evidence-based guidelines regarding the use of triclosan on medical devices or consumables for infection prevention will be reviewed. This information may be used to inform decision making relating to health policy of the use of triclosan on single use medical devices or consumables
|